BioCardia, Inc.BCDANASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Latest
0.00%
↓ 100% vs avg
Percentile
P50
Within normal range
Average
190.91%
Historical baseline
PeriodValue
20250.00%
20240.00%
20230.00%
2022-100.00%
2021-13.21%
2020-2.37%
20194.27%
2018-9.98%
201755.67%
20161974.75%